2007-08-22T00:00:00
The National Institute for Health and Clinical Excellence has approved the drug rituximab (Mabthera) for patients with severe arthritis in England and Wales.
With a HSJ subscription you’ll unlock:
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud